<DOC>
	<DOCNO>NCT00586950</DOCNO>
	<brief_summary>The aim multi-center study determine applicability BMIPP diagnose cardiac disease predict outcome patient hemodialysis .</brief_summary>
	<brief_title>123I-BMIPP SPECT Analysis Decreasing Cardiac Events Hemodialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>Adult hemodialysis patient one follow 10 risk factor coronary heart disease Hypertension Diabetes mellitus Hyperlipidemia Obliterative arteriosclerosis low extremity Smoker Family history juvenile coronary artery disease History ischemic stroke History heart failure require hospitalization Within 3 month initiation hemodialysis therapy Dialysis hypotension Hemodialysis patient meet one follow condition exclude . Peritoneal dialysis Severe valvular disorder require treatment Diagnosis hypertrophic cardiomyopathy ( HCM ) dilate cardiomyopathy ( DCM ) start dialysis History revascularization ( PCI , CABG ) prior diagnosis myocardial infarction Hypersensitivity BMIPP analogue Judged unsuitable study reason physician .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Myocardial Free Fatty Acid metabolism</keyword>
	<keyword>High risk patient</keyword>
	<keyword>End-stage renal failure</keyword>
	<keyword>Cardiovascular event</keyword>
	<keyword>prognosis</keyword>
</DOC>